Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

7.7%

3 terminated/withdrawn out of 39 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

26%

10 trials in Phase 3/4

Results Transparency

0%

0 of 24 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
14(43.8%)
Phase 3
5(15.6%)
Phase 4
5(15.6%)
N/A
4(12.5%)
Phase 1
3(9.4%)
Early Phase 1
1(3.1%)
32Total
Phase 2(14)
Phase 3(5)
Phase 4(5)
N/A(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials
NCT04229459Phase 2Active Not Recruiting

Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Role: collaborator

NCT07094893Phase 4Not Yet Recruiting

Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status

Role: collaborator

NCT02710448Phase 2Completed

May Metformin be Used in Renal Failure?

Role: collaborator

NCT01884623Phase 3Completed

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer

Role: collaborator

NCT03727724Phase 2Completed

Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer

Role: collaborator

NCT03914170Completed

Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

Role: collaborator

NCT03324633Completed

Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV

Role: collaborator

NCT03524820Phase 2Terminated

Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer

Role: collaborator

NCT02054442Phase 1Unknown

A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck

Role: collaborator

NCT01867697Phase 2Completed

Nordic 8 - A Phase II Trial

Role: collaborator

NCT03356964Early Phase 1Completed

Step Down FSH Approach and Late Follicular Phase in Progesterone Level

Role: collaborator

NCT04115072Phase 2Completed

Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study

Role: collaborator

NCT02017561Phase 2Completed

Metformin in the Diastolic Dysfunction of Metabolic Syndrome

Role: collaborator

NCT01230476Phase 2Terminated

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

Role: collaborator

NCT03290911Completed

Retrospective Trial on Low Prognosis Infertile Patients

Role: collaborator

NCT03222765Not ApplicableUnknown

Prevention of Microvascular Complications in Prediabetes e-PREDICE Study

Role: collaborator

NCT01565265Not ApplicableCompleted

Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression

Role: collaborator

NCT02142764Not ApplicableCompleted

Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients

Role: collaborator

NCT01050426Phase 2Terminated

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Role: collaborator

NCT02072564Completed

Influence of Diet and Lifestyle Factors on the Results of the IVF

Role: collaborator